BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:NNC4005-001 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of NNC4005-001\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07214870-6903@assetmemo.bio
DTSTAMP:20261121T005735Z
DTSTART;VALUE=DATE:20270514
DTEND;VALUE=DATE:20270515
SUMMARY:NNC4005-001: Phase 1 readout est. (NCT07214870)
DESCRIPTION:NNC4005-001\, phase 1.\nStudy: A Research Study of a Potential 
 New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With I
 ncreased Body Weight and Liver Fat\nEstimated primary completion: 14 May 2
 027. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\
 , and it can move.\nDrug page: https://assetmemo.bio/drug/nnc4005-001#upco
 ming-events\nRegistry record: https://clinicaltrials.gov/study/NCT07214870
URL:https://assetmemo.bio/drug/nnc4005-001#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
